Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2285)
All Articles published online
|
Sep 28, 2005 (publication date) through Jun 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu ZL, Zou SQ, Cui NQ, Wu XZ, Qin MF, Kong D, Zhou ZL. Upregulation of human telomerase reverse transcriptase mRNA expression by in vitro transfection of hepatitis B virus X gene into human hepatocarcinoma and cholangiocarcinoma cells. World J Gastroenterol 2005; 11(36): 5627-5632 [PMID: 16237755 DOI: 10.3748/wjg.v11.i36.5627] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i36/5627.htm |
| Number | Citing Articles |
| 1 |
Thomas Tu, Sandra Bühler, Ralf Bartenschlager. Chronic viral hepatitis and its association with liver cancer. Biological Chemistry 2017; 398(8): 817 doi: 10.1515/hsz-2017-0118
|
| 2 |
Mark A. Feitelson, Jungmin Lee. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Letters 2007; 252(2): 157 doi: 10.1016/j.canlet.2006.11.010
|
| 3 |
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinoma. Journal of Viral Hepatitis 2013; 20(5): 297 doi: 10.1111/jvh.12093
|
| 4 |
|
| 5 |
Enakshi Sivasudhan, Neil Blake, Zhiliang Lu, Jia Meng, Rong Rong. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review. Cells 2022; 11(4): 741 doi: 10.3390/cells11040741
|
| 6 |
Zhenliang QU, Naiqiang CUI, Mingfang QIN, Xianzhong WU. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Asia-Pacific Journal of Clinical Oncology 2012; 8(1): 83 doi: 10.1111/j.1743-7563.2011.01466.x
|
| 7 |
Mehmet Ozturk, Ayca Arslan-Ergul, Sevgi Bagislar, Serif Senturk, Haluk Yuzugullu. Senescence and immortality in hepatocellular carcinoma. Cancer Letters 2009; 286(1): 103 doi: 10.1016/j.canlet.2008.10.048
|
| 8 |
Ashraf Ali, Hany Abdel-Hafiz, Mohd Suhail, Amany Al-Mars, Mohammad Khalid Zakaria, Kaneez Fatima, Sultan Ahmad, Esam Azhar, Adeel Chaudhary, Ishtiaq Qadri. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(30): 10238-10248 doi: 10.3748/wjg.v20.i30.10238
|
| 9 |
Jun-hui Li, Chuan-hong Tang, Chun-yan Song, Ming-jie Chen, Zhi-yong Feng, Ying-jie Pan. A simple, rapid and effective method for total RNA extraction from Lentinula edodes. Biotechnology Letters 2006; 28(15): 1193 doi: 10.1007/s10529-006-9074-y
|
| 10 |
Lei Zhang, Jian‐Qiang Cai, Jian‐Jun Zhao, Xin‐Yu Bi, Xiao‐Gang Tan, Tao Yan, Cong Li, Ping Zhao. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2010; 101(3): 233 doi: 10.1002/jso.21488
|
| 11 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|
| 12 |
Thomas Tu, Magdalena A. Budzinska, Nicholas A. Shackel, Allison R. Jilbert. Conceptual models for the initiation of hepatitis B virus‐associated hepatocellular carcinoma. Liver International 2015; 35(7): 1786 doi: 10.1111/liv.12773
|
| 13 |
Young‐Joo Kim, Jeong Eun Yoo, Youngsic Jeon, Jae Uk Chong, Gi Hong Choi, Dae‐Geun Song, Sang Hoon Jung, Bong‐Kyeong Oh, Young Nyun Park. Suppression of PROX1‐mediated TERT expression in hepatitis B viral hepatocellular carcinoma. International Journal of Cancer 2018; 143(12): 3155 doi: 10.1002/ijc.31731
|
| 14 |
Ali Salimi-Jeda, Fariba Badrzadeh, Maryam Esghaei, Asghar Abdoli. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches. Cancer Treatment and Research Communications 2021; 27: 100323 doi: 10.1016/j.ctarc.2021.100323
|
| 15 |
Matthew Hoare, Tapas Das, Graeme Alexander. Ageing, telomeres, senescence, and liver injury. Journal of Hepatology 2010; 53(5): 950 doi: 10.1016/j.jhep.2010.06.009
|
| 16 |
Pinar Ozkal-Baydin. How did hepatitis B virus effect the host genome in the last decade?. World Journal of Hepatology 2014; 6(12): 851-859 doi: 10.4254/wjh.v6.i12.851
|
| 17 |
Michael C Kew. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(s1): 144 doi: 10.1111/j.1440-1746.2010.06546.x
|
| 18 |
Yanming Zhou, Yanfang Zhao, Bin Li, Jiyi Huang, Lupeng Wu, Donghui Xu, Jiamei Yang, Jia He. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-289
|
| 19 |
Jiun-Ming Su, Xiang-Me Lai, Keng-Hsin Lan, Chung-Pin Li, Yee Chao, Sang-Hue Yen, Full-Young Chang, Shou-Dong Lee, Wei-Ping Lee. X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter. Hepatology 2007; 46(2): 402 doi: 10.1002/hep.21675
|
| 20 |
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatology Research 2021; 51(1): 102 doi: 10.1111/hepr.13580
|
| 21 |
Xiao-Bo Xu, Chen Hu, Han-Jin Yang, Shu-Sen Zheng. Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection. Hepatobiliary & Pancreatic Diseases International 2022; 21(5): 472 doi: 10.1016/j.hbpd.2022.07.010
|
| 22 |
Vito Sansone, Marco Le Grazie, Jenny Roselli, Simone Polvani, Andrea Galli, Francesco Tovoli, Mirko Tarocchi. Telomerase reactivation is associated with hepatobiliary and pancreatic cancers. Hepatobiliary & Pancreatic Diseases International 2020; 19(5): 420 doi: 10.1016/j.hbpd.2020.04.007
|
| 23 |
Mark A. Feitelson, Alla Arzumanyan, Helena M. G. P. V. Reis, Marcia M. Clayton, Bill S. Sun, Zhaorui Lian. Molecular Pathology of Liver Diseases. Molecular Pathology Library 2011; 5: 553 doi: 10.1007/978-1-4419-7107-4_37
|
| 24 |
Manale El Idrissi, Valérie Hervieu, Philippe Merle, Franck Mortreux, Eric Wattel. Cause-specific telomere factors deregulation in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-64
|
| 25 |
Chet W. Hammill, Linda L. Wong. Intrahepatic Cholangiocarcinoma: A Malignancy of Increasing Importance. Journal of the American College of Surgeons 2008; 207(4): 594 doi: 10.1016/j.jamcollsurg.2008.04.031
|